Gout
A pilot trial tested a specific purine-degrading gut bacterium head-to-head against standard gout medication over 6 months.

A bacterium that actually breaks down the trigger molecule
Gout is caused by excess uric acid, which forms from the breakdown of purines, compounds found in certain foods and also produced by the body. Researchers identified a specific bacterium, Ligilactobacillus salivarius, that can directly metabolise purine-related compounds, including inosine, guanosine, and uric acid itself, in laboratory testing, giving a genuinely specific, mechanistic reason to expect a real effect rather than a vague gut-health claim.
Confirmed with a direct germ-free mouse experiment
A separate, more fundamental experiment adds direct support to this idea. Humans lost the ability to break down uric acid further using an enzyme called uricase far back in evolutionary history, leaving gut bacteria to help pick up some of that job instead. Researchers colonised germ-free mice, bred without uricase and without any gut bacteria of their own, with either purine-degrading bacteria or bacteria lacking the relevant genes. The mice given purine-degrading bacteria had significantly lower uric acid levels than those given bacteria without this capability, direct evidence that specific gut bacteria genuinely lower uric acid, not just correlate with lower levels.
Source: The Gut Microbiome in Hyperuricemia and Gout
A head-to-head pilot trial against standard treatment
A pilot randomised controlled trial gave 30 people with hyperuricemia and a history of recurrent gout either the specific strain Ligilactobacillus salivarius CECT 30632 or allopurinol, the standard urate-lowering medication, for 6 months. This kind of head-to-head design against an established treatment, rather than against placebo alone, is a meaningfully more rigorous test of whether a probiotic could offer genuine benefit.
Source: A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632
A distinct gut bacteria pattern in gout, and an honest caveat
People with gout consistently show a distinctive gut bacteria pattern, including reduced diversity and lower levels of Akkermansia and Bifidobacterium. Antibiotic use that wipes out gut bacteria broadly, particularly antibiotics targeting anaerobic bacteria, has also been linked to a heightened risk of developing gout, a further hint that the purine-degrading bacteria discussed above play a genuinely protective role when left intact. That said, a broader review of this research area was honest that clinical trials involving probiotics for gout show only slight reductions in uric acid so far, and that study quality and duration vary considerably, meaning more rigorous, larger trials are still needed before firm conclusions can be drawn.
As with any probiotic, a purine-degrading strain like the one above only works if it's properly fed and able to establish itself in the gut, rather than simply passing through.
What this means for you
Gout needs proper diagnosis and, for most people, standard urate-lowering medication such as allopurinol remains the well-established, most effective long-term treatment, particularly for preventing future flares. Given the genuinely specific mechanism and early pilot trial evidence above, it's reasonable to ask a doctor about a specific probiotic strain as a complementary approach, especially if standard medication isn't fully controlling flares, though it shouldn't replace prescribed treatment on the strength of this evidence alone. A varied, plant-rich diet supports the same gut bacteria this research ties to healthier uric acid levels. That's the same idea behind GutLab, everyday gut health starts with regularly feeding the microbiome a broad range of plant-rich ingredients.

Educational information only
The information on this website is for educational purposes only and is not medical advice. Always consult a qualified health professional for personalised guidance.


.jpg)
.jpg)
